C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/25 (2006.01) A61K 38/20 (2006.01) A61P 37/06 (2006.01) C07K 14/54 (2006.01) C07K 14/545 (2006.01) C12N 5/10 (2006.01) C12N 15/63 (2006.01) C12P 21/02 (2006.01)
Patent
CA 2202470
It is described a new interleukin-1 antagonist active both against IL-1a and IL-1B, a new DNA sequence encoding the IL-1 antagonist and the method for obtaining a IL-1 antagonist by the recombinant DNA technique; it is also described the prophylactic, therapeutic and diagnostic use of such new IL-1 antagonist in pathologies deriving from the IL- 1 production.
On décrit un nouvel antagoniste de l'interleukine-1, actif à la fois contre IL-1a et IL-1B, une nouvelle séquence d'ADN codant l'antagoniste d'IL-1 ainsi qu'un procédé de production d'un antagoniste d'IL-1 à l'aide d'une technique d'ADN recombiné. On décrit également l'utilisation prophylactique, thérapeutique et diagnostique de ce nouvel antagoniste d'IL-1 dans des pathologies consécutives à la production d'IL-1.
Colotta Francesco
Mantovani Alberto
Muzio Marta
Applied Research Systems Ars Holding N.v.
Kirby Eades Gale Baker
Laboratoires Serono S.a.
LandOfFree
Intracellular isoform of the interleukin-1-receptor antagonist does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Intracellular isoform of the interleukin-1-receptor antagonist, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Intracellular isoform of the interleukin-1-receptor antagonist will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1880411